Has the FDA issued any safety alerts regarding Avandia?

Yes.  The FDA has issued safety alerts about the use, and side effects of using, Avandia.  In addition, the FDA has conducted long investigations into its safety.

FDA ALERT #1: 5/21/2007, updated 11/19/2007:  The FDA added a new warning about the risk of myocardial ischemia to the boxed warning for Avandia, for treatment of Type 2 Diabetes.

FDA ALERT #2: 8/14/2007: The FDA issued important revisions to the full prescribing information (labeling) highlighting increased risks of congestive heart failure associated with rosiglitazone.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Additional Avandia Articles

Search LawInfo's Avandia Resources